By Roots Over 80 firms are involved in providing antibody drug discovery-related services; whereas close to 125 players are offering antibody discovery platforms

According to experts in this field, the industry is investigating antibodies against novel targets which are expected to drive the market in the coming years. In fact, many service provider and platform provider companies are offering support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.

 

• An overview of the overall landscape of antibody discovery service providers along with the information on a number of parameters, such as year of establishment, company size, location of headquarters, type of service offered (antigen designing, hit generation, lead selection, and lead optimization and lead characterization), type of antibody discovery method (hybridoma based, library based, single cell based, transgenic animal based, and others), animal model used (rabbit, rat, mouse, llama, chicken, transgenic animal and others), type of antibody discovered (monoclonal antibody, bispecific antibody, single domain antibody, antibody drug conjugate, antibody fragment and others) and purpose of antibody discovery (therapeutic and diagnostic).
• An insightful competitiveness analysis of antibody discovery service providers, based on supplier strength (based on a company's employee count and years of experience) and service portfolio specifications, such as number of antibody discovery services offered, number of antibody discovery methods adopted, and number of subject specific agreements signed.
• Elaborate profiles of antibody discovery service providers. Each company profile features a brief overview of the company, its financial information (if available), antibody discovery service portfolios and an informed future outlook.
• A detailed review of the overall landscape of antibody discovery platforms, along with the information on the technology developers such as year of establishment, company size, location of headquarters and type of antibody discovered (monoclonal antibody, bispecific antibody, single domain antibody, antibody drug conjugate, antibody fragment and others). In addition, the chapter highlights an in-depth analysis of antibody discovery platforms based on type of antibody discovery method (hybridoma based, library-based, single cell-based, transgenic animal-based, and others), animal model used (rabbit, rat, mouse, llama, chicken, transgenic animal and others) and availability of intellectual property.

 

To order this 500+ page report, which features 120+ figures and 140+ tables, please visit this link

 

The USD 6.5 billion (by 2030) financial opportunity within the antibody discovery services market has been analyzed across the following segments:

• Steps Involved in the Antibody Discovery Process
• Antigen Designing
• Hit Generation
• Lead Selection
• Lead Optimization
• Lead Characterization

 

• • Antibody Discovery Method Used
• Phage Display
• Hybridoma
• Transgenic Animal
• Yeast Display
• Single Cell
• Others

 

• • Nature of Antibody Generated
• Humanized
• Human
• Chimeric
• Murine

 

• Key Geographical Regions
• North America
• Europe
• Asia Pacific and Rest of the World

 

The USD 5.9 billion (by 2030) financial opportunity within the antibody discovery platforms market has been analysed across the following segments:

• • Type of Payment
• Upfront Payments
• Milestone Payments

 

• Key Geographical Regions
• North America
• Europe
• Asia Pacific

 

 

The Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:

• Abzena
• Abwiz Bio
• Aragen Bioscience
• BIOTEM
• ChemPartner
• Creative Biolabs
• Distributed Bio

Press Release: Variation 3 (Format 4)

 

• Harbour BioMed
• HD Biosciences
• ImmunoPrecise Antibodies
• Integral Molecular
• Kymab
• LakePharma
• Ligand Pharmaceuticals
• MorphoSys
• PX’Therapeutics
• Syd Labs
• Viva Biotech
• Wuxi Biologics

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction
 

4. Antibody Discovery Process and Methods

 

5. Antibody Discovery Service Providers: Current Market Landscape

 

6. Company Competitiveness Analysis
 

7. Company Profiles: Antibody Discovery Service Providers
 

8. Antibody Discovery Technologies: Current Market Landscape
 

9. Technology Competitiveness Analysis
 

10. Company Profiles: Antibody Discovery Platform Providers
 

11. Regional Capability Analysis

 

12. Partnerships and Collaborations

 

13. Funding and Investment Analysis

 

14. Antibody Discovery Services: Market Forecast

 

15. Antibody Discovery Technologies: Market Forecast

 

16. Case in Point: Drug Discovery Processes of Top Selling Antibodies

 

17. Case Study: Antibody Humanization and Affinity Maturation

 

18. Future Growth Opportunities

 

19. Executive Insights

 

20. Concluding Remarks

 

21. Appendix 1: Tabulated Data

 

22. Appendix 2: List of Companies and Organizations

 

 

Press Release: Variation 3 (Format 4)

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]